Joris R. de Groot

10.4k total citations
219 papers, 5.8k citations indexed

About

Joris R. de Groot is a scholar working on Cardiology and Cardiovascular Medicine, Epidemiology and Surgery. According to data from OpenAlex, Joris R. de Groot has authored 219 papers receiving a total of 5.8k indexed citations (citations by other indexed papers that have themselves been cited), including 203 papers in Cardiology and Cardiovascular Medicine, 27 papers in Epidemiology and 16 papers in Surgery. Recurrent topics in Joris R. de Groot's work include Cardiac Arrhythmias and Treatments (128 papers), Atrial Fibrillation Management and Outcomes (116 papers) and Cardiac electrophysiology and arrhythmias (78 papers). Joris R. de Groot is often cited by papers focused on Cardiac Arrhythmias and Treatments (128 papers), Atrial Fibrillation Management and Outcomes (116 papers) and Cardiac electrophysiology and arrhythmias (78 papers). Joris R. de Groot collaborates with scholars based in Netherlands, Germany and United States. Joris R. de Groot's co-authors include Arthur A.M. Wilde, Ruben Coronel, Reinoud E. Knops, Louise R.A. Olde Nordkamp, Antoine H.G. Driessen, Jacques M.T. de Bakker, Barbara J.M. Mulder, Berto J. Bouma, André C. Linnenbank and Wim Jan van Boven and has published in prestigious journals such as The Lancet, Circulation and Nature Communications.

In The Last Decade

Joris R. de Groot

201 papers receiving 5.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Joris R. de Groot Netherlands	40	5.2k	938	665	507	285	219	5.8k
Dominique Babuty France	35	4.6k 0.9×	1.2k 1.3×	342 0.5×	549 1.1×	274 1.0×	208	5.2k
Claudia Stöllberger Austria	34	3.8k 0.7×	1.6k 1.7×	329 0.5×	756 1.5×	351 1.2×	278	4.9k
James E. Ip United States	32	7.6k 1.5×	519 0.6×	310 0.5×	1.2k 2.3×	566 2.0×	189	8.9k
Maurizio Gasparini Italy	45	7.1k 1.4×	1.7k 1.8×	217 0.3×	751 1.5×	234 0.8×	182	8.2k
Michael Eldar Israel	40	4.8k 0.9×	1.5k 1.6×	187 0.3×	740 1.5×	487 1.7×	156	5.5k
Lucas V.A. Boersma Netherlands	44	7.9k 1.5×	298 0.3×	241 0.4×	631 1.2×	670 2.4×	226	8.2k
Jonathan J. Langberg United States	47	8.3k 1.6×	339 0.4×	240 0.4×	1.2k 2.3×	367 1.3×	170	9.0k
Pierre Pagé Canada	34	2.7k 0.5×	316 0.3×	457 0.7×	933 1.8×	153 0.5×	138	3.4k
Fırat Duru Switzerland	34	3.4k 0.7×	464 0.5×	198 0.3×	395 0.8×	689 2.4×	269	4.3k
Morio Shoda Japan	21	3.4k 0.7×	615 0.7×	141 0.2×	283 0.6×	144 0.5×	196	3.7k

Countries citing papers authored by Joris R. de Groot

Since Specialization

Citations

This map shows the geographic impact of Joris R. de Groot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joris R. de Groot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joris R. de Groot more than expected).

Fields of papers citing papers by Joris R. de Groot

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joris R. de Groot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joris R. de Groot. The network helps show where Joris R. de Groot may publish in the future.

Co-authorship network of co-authors of Joris R. de Groot

This figure shows the co-authorship network connecting the top 25 collaborators of Joris R. de Groot. A scholar is included among the top collaborators of Joris R. de Groot based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joris R. de Groot. Joris R. de Groot is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hopman, Luuk H G A, et al.. (2025). Right atrial reverse remodeling after pulmonary vein isolation: Analyzing changes in volume and function using cardiac magnetic resonance imaging. Heart Rhythm. 22(10). 2543–2550.

Hopman, Luuk H G A, et al.. (2025). Left atrial volumetric and functional remodeling post-pulmonary vein isolation: Insights from cardiac magnetic resonance imaging. Journal of Cardiovascular Magnetic Resonance. 27(2). 101937–101937.

Musikantow, Daniel R., Vivek Y. Reddy, Tamaz Shaburishvili, et al.. (2024). Epicardial Pulsed Field Ablation for the Treatment of Paroxysmal Atrial Fibrillation During Cardiac Surgery. JACC. Clinical electrophysiology. 10(9). 2097–2099. 1 indexed citations

Kirchhof, Paulus, Ameet Bakhai, Carlo de Asmundis, et al.. (2024). Long-term effectiveness and safety of edoxaban in patients with atrial fibrillation: 4-year data from the ETNA-AF-Europe study. International Journal of Cardiology. 408. 132118–132118. 1 indexed citations

Meulendijks, Eva R., Robin Wesselink, Ruben N. van Veen, et al.. (2024). The change of epicardial adipose tissue characteristics and vulnerability for atrial fibrillation upon drastic weight loss. Adipocyte. 13(1). 2395565–2395565. 3 indexed citations

Hemels, Martin E W, et al.. (2023). The Use of Oral Anticoagulation Is Not Independently Associated with Mortality in Frail Older Patients with Repeated Falls. Journal of Clinical Medicine. 12(23). 7388–7388. 2 indexed citations

Bracht, Jillian Wilhelmina Paulina, Chi M. Hau, Shirley C.M. van Amersfoorth, et al.. (2023). MicroRNAs in extracellular vesicles released from epicardial adipose tissue promote arrhythmogenic conduction slowing. Heart Rhythm O2. 4(12). 805–814. 10 indexed citations

Meulendijks, Eva R., Robin Wesselink, Wim Jan van Boven, et al.. (2023). PO-02-177 EPICARDIAL ADIPOSE TISSUE NEUTROPHIL INFLAMMATION RELATES TO SEVERITY BUT NOT TO RECURRENCE OF ATRIAL FIBRILLATION AND IS REFLECTED BY ATTENUATION IN CTA SCANS. Heart Rhythm. 20(5). S270–S271. 1 indexed citations

Toennis, Tobias, Emanuele Bertaglia, Axel Brandes, et al.. (2023). The influence of atrial high-rate episodes on stroke and cardiovascular death: an update. EP Europace. 25(7). 23 indexed citations

10.

Jansen, R.W.M.M., Joris R. de Groot, Martin E W Hemels, et al.. (2023). Does atrial fibrillation affect prognosis in hospitalised COVID-19 patients? A multicentre historical cohort study in the Netherlands. BMJ Open. 13(12). e071137–e071137. 3 indexed citations

11.

Meulendijks, Eva R., Sébastien P.J. Krul, Sarah W.E. Baalman, et al.. (2022). Circulating adipose tissue proteins involved in atrial fibrillation: An explorative scoping review. Trends in Cardiovascular Medicine. 34(3). 148–158. 9 indexed citations

12.

Kirchhof, Paulus, Ladislav Pecen, Ameet Bakhai, et al.. (2022). Edoxaban for stroke prevention in atrial fibrillation and age-adjusted predictors of clinical outcomes in routine clinical care. European Heart Journal - Cardiovascular Pharmacotherapy. 9(1). 47–57. 9 indexed citations

13.

Hemels, Martin E W, Frank Cools, Harry J.G.M. Crijns, et al.. (2021). Characteristics of patients with atrial fibrillation prescribed edoxaban in Belgium and The Netherlands: insights from the ETNA-AF-Europe study. Acta cardiologica. Supplementum. 76(4). 431–439.

14.

Stuijt, Willeke van der, Sarah W.E. Baalman, Tom F. Brouwer, et al.. (2020). Long‐term follow‐up of the two‐incision implantation technique for the subcutaneous implantable cardioverter‐defibrillator. Pacing and Clinical Electrophysiology. 43(12). 1476–1480. 8 indexed citations

15.

Reyat, Jasmeet S., Winnie Chua, Victor Roth Cardoso, et al.. (2020). Reduced left atrial cardiomyocyte PITX2 and elevated circulating BMP10 predict atrial fibrillation after ablation. JCI Insight. 5(16). 50 indexed citations

16.

Dijk, Vincent F. van, Anne‐Floor B.E. Quast, Jeroen Schaap, et al.. (2020). ICD implantation for secondary prevention in patients with ventricular arrhythmia in the setting of acute cardiac ischemia and a history of myocardial infarction. Journal of Cardiovascular Electrophysiology. 31(2). 536–543. 6 indexed citations

17.

Baalman, Sarah W.E., Nicoline W.E. van den Berg, Jolien Neefs, et al.. (2019). P2454Left atrial strain and recurrence of atrial fibrillation after thoracoscopic atrial fibrillation surgery. European Heart Journal. 40(Supplement_1). 1 indexed citations

18.

Bertaglia, Emanuele, Benjamin Blank, Carina Blomström‐Lundqvist, et al.. (2019). Atrial high-rate episodes: prevalence, stroke risk, implications for management, and clinical gaps in evidence. EP Europace. 21(10). 1459–1467. 44 indexed citations

19.

Vehmeijer, Jim T., Michiel Hulleman, Joey M. Kuijpers, et al.. (2018). Resuscitation for out-of-hospital cardiac arrest in adults with congenital heart disease. International Journal of Cardiology. 278. 70–75. 2 indexed citations

20.

Nordkamp, Louise R.A. Olde, et al.. (2013). Which Patients Are Not Suitable for a Subcutaneous ICD: Incidence and Predictors of Failed QRS‐T‐Wave Morphology Screening. Journal of Cardiovascular Electrophysiology. 25(5). 494–499. 104 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact